An Evaluation of the Efficacy of High-dose Hepatitis B Vaccine in Patients Using Biological Agents


AYDIN M., AKSOY F., Yildirim Z., Koksal I.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, vol.26, no.2, pp.88-93, 2020 (Journal Indexed in ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 2
  • Publication Date: 2020
  • Doi Number: 10.4274/vhd.galenos.2020.2019.0039
  • Title of Journal : VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
  • Page Numbers: pp.88-93

Abstract

Objectives: Hepatitis B virus (HBV) vaccination is efficient in the normal population, whereas lower humoral response rates in immunosuppressed patients. Biological agents used in the treatment of several diseases in recent years are a significant cause of immunosuppression in patients. In this study we aimed to evaluate the efficacy of double-dose HBV vaccination at months 0, 1, 2, and 6 in patients using biological agents.